Flagellate dermatitis in bleomycin chemotherapy: a causality?

Area of Science:

• Dermatology
• Oncology
• Toxicology

Background:

• Flagellate dermatitis is an uncommon skin reaction characterized by linear, erythematous lesions.
• It is frequently associated with the chemotherapeutic agent bleomycin.
• The condition's etiology involves various triggers, with bleomycin being the most prevalent.

Observation:

• This report details two distinct cases of flagellate dermatitis.
• Both patients developed the characteristic skin lesions following bleomycin administration.

Findings:

• The first case involved a patient diagnosed with germ cell carcinoma.
• The second case involved a patient with osteosarcoma.
• Both patients exhibited flagellate dermatitis as a reaction to bleomycin treatment.

Implications:

• This highlights the importance of recognizing flagellate dermatitis as a potential adverse effect of bleomycin.
• Awareness of this reaction is crucial for oncologists and dermatologists managing patients treated with bleomycin.
• Prompt identification can aid in managing treatment toxicity and patient care.